Are insiders buying AGMB stock?

Yes — 3 distinct insiders have bought AGMB (AgomAb Therapeutics NV) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Oct 7, 2026.

How much AGMB stock have insiders bought?

Insiders have bought a combined $266.7K of AGMB across 7 open-market purchases, based on SEC Form 4 filings.

What is an insider cluster buy in AGMB?

A cluster buy is two or more distinct AgomAb Therapeutics NV insiders — officers, directors, or 10% owners — each buying AGMB on the open market within a rolling window. AGMB has 2 detected cluster buys to date.

Where does this AGMB insider trading data come from?

Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

AGMB insider buying

2 cluster buys

AgomAb Therapeutics NV

When two or more insiders at AgomAb Therapeutics NV buy AGMB on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in AGMB plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters

Distinct insiders

Total bought

$266.7K

Market cap

Unknown

Detected clusters

Oct 5 – Oct 6, 2026
Detected Oct 7, 2026
High conviction3 insiders
Total bought
$266.7K
Market cap
Unknown
Oct 5 – Oct 6, 2026
Detected Oct 7, 2026
High conviction2 insiders
Total bought
$180.3K
Market cap
Unknown

All notable open-market buys in AGMB

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

Date	Insider	Shares	Price	Value	Filing
Oct 6, 2026	Epstein David Rcluster Director	5,000	$8.70	$43.5K	SEC ↗
Oct 6, 2026	Knotnerus Tim Jaspercluster Director, Chief Executive Officer	5,000	$8.70	$43.5K	SEC ↗
Oct 6, 2026	Kemula Pierre Thadee Victorcluster Chief Financial Officer	5,000	$8.57	$42.9K	SEC ↗
Oct 6, 2026	Kemula Pierre Thadee Victorcluster Chief Financial Officer	3,000	$8.67	$26.0K	SEC ↗
Oct 6, 2026	Kemula Pierre Thadee Victorcluster Chief Financial Officer	2,000	$8.54	$17.1K	SEC ↗
Oct 5, 2026	Knotnerus Tim Jaspercluster Director, Chief Executive Officer	6,000	$8.48	$50.9K	SEC ↗
Oct 5, 2026	Epstein David Rcluster Director	5,000	$8.57	$42.9K	SEC ↗

AGMB insider buying — FAQ

Are insiders buying AGMB stock?: Yes — 3 distinct insiders have bought AGMB (AgomAb Therapeutics NV) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Oct 7, 2026.
How much AGMB stock have insiders bought?: Insiders have bought a combined $266.7K of AGMB across 7 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in AGMB?: A cluster buy is two or more distinct AgomAb Therapeutics NV insiders — officers, directors, or 10% owners — each buying AGMB on the open market within a rolling window. AGMB has 2 detected cluster buys to date.
Where does this AGMB insider trading data come from?: Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in AGMB

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy AGMB within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding AGMB.